Novel and potent human and rat β3-adrenergic receptor agonists containing substituted 3-indolylalkylamines

Bioorganic and Medicinal Chemistry Letters

Volumn 13, Issue 7, 2003, Pages 1301-1305

  Harada, Hiroshi ^a   Hirokawa, Yoshimi ^a   Suzuki, Kenji ^a   Hiyama, Yoichi ^a   Oue, Mayumi ^a   Kawashima, Hitoshi ^a   Yoshida, Naoyuki ^a   Furutani, Yasuji ^a   Kato, Shiro ^a  

^a DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALIPHATIC AMINE; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT; CYCLIC AMP;

ANIMAL CELL; ARTICLE; CHO CELL; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG ACTIVITY; DRUG POTENCY; DRUG SCREENING; DRUG SELECTIVITY; MOLECULAR CLONING; NONHUMAN; OPTICAL ROTATION; STRUCTURE ACTIVITY RELATION;

CRICETINAE; CRICETULUS GRISEUS;

EID: 0037424703     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(03)00073-8     Document Type: Article

References (29)

1. Lands A.M., Arnold A., McAuliff J.P., Luduena F.P., Brown T.G. Jr. Nature. 214:1967;597.
2. Arch J.R.S. Proc. Nutrition Soc. 48:1989;215.
3. Emorine L.J., Marullo S., Briend-Sutren M.-M., Patey G., Tate K., Delavier-Klutchko C., Strosberg A.D. Science. 245:1989;1118.
4. Tan S., Curtis-Prior P.B. Int. J. Obesity. 7:1983;409.
5. Granneman J.G., Lahners K.N., Chaudhry A. Mol. Pharmacol. 40:1991;895.
6. Muzzin P., Revelli J.-P., Kuhne F., Gocayne J.D., McCombie W.R., Venter J.C., Giacobino J.-P., Fraser C.M. J. Biol. Chem. 266:1991;24053.
7. Nahmias C., Blin N., Elalouf J.-M., Mattei M.G., Strosberg A.D. EMBO. J. 10:1991;3721.
8. Lafonate M., Berlan M.J. Lipid Res. 34:1993;1057.
9. (a) Weyer C., Gautier J.F., Danforth E. Jr. Diabetes Metab. 25:1999;11.
10. (b) Souza J.C., Burkey B.F. Curr. Pharm. Des. 7:2001;1433.
11. (c) Weber A.E. Annu. Rep. Med. Chem. 33:1998;193.
12. Cantello B.C.C., Smith S.A. Drugs Future. 16:1991;797.
13. Bloom J.D., Claus T.H. Drugs Future. 19:1994;23.
14. Cecchi R., Croci T., Boigegrain R., Boveri S., Baroni M., Boccardi G., Guimbard J.P., Guzzi U. Eur. J. Med. Chem. 29:1994;259.
15. (a) Arch J.R.S., Wilson S. Int. J. Obesity. 20:1996;191.
16. (b) Howe R. Drugs Future. 18:1993;529.
17. (a) Lipworth B.J. J. Clin. Pharmacol. 42:1996;291.
18. (b) Strosberg A.A. Annu. Rev. Pharmacol. Toxicol. 37:1997;421.
19. Liggett S. Mol. Pharm. 42:1992;634.
20. (a) 3-(2-Aminopropyl)indole, 3-(2-aminobutyl)indole: Heinzelman R.V., Anthony W.C., Lyttle D.A., Szmuszkovicz Z. J. Org. Chem. 25:1960;1548.
21. (b) Bergman J., Bäckvall J.-E., Lindström J.-O. Tetrahedron. 29:1973;971.
22. 3-(2-Amino-2-methylpropyl)indole: Snyder H.R., Katz L. J. Am. Chem. Soc. 69:1947;3140. 3-Amino-1,2,3,4-tetrahydrocarbazole: Mooradian A., Dupont P.E., Hlavac A.G., Aceto M.D., Pearl J. J. Med. Chem. 20:1977;487.
23. 3-(2-Amino-2-methylpropyl)indole: Snyder H.R., Katz L. J. Am. Chem. Soc. 69:1947;3140. 3-Amino-1,2,3,4-tetrahydrocarbazole: Mooradian A., Dupont P.E., Hlavac A.G., Aceto M.D., Pearl J. J. Med. Chem. 20:1977;487.
24. Bloom J.D., Dutia M.D., Johnson B.D., Wissner A., Burns M.G., Largis E.E., Dolan J.A., Claus T.H. J. Med. Chem. 35:1992;3081.
25. Collet A., Jacques J. Bull. Soc. Chim. Fr. 1973;3330.
26. Repk D.B., Ferguson W.J. J. Heterocyclic Chem. 13:1976;775.
27. 6); 0.93 (3H, d, J=6.0 Hz), 2.5-3.3 (8H, m), 4.55 (2H, s), 4.85 (1H, dd, J=9.8, 2.6 Hz), 6.42 (1H, d, J=7.8 Hz), 6.78 (1H, t, J=7.8 Hz), 6.94 (1H, d, J=2.0 Hz), 6.99 (1H, d, J=7.8 Hz), 7.27-7.33 (3H, m), 7.46 (1H, s), 11.02 (1H, s).
28. Takeda Y., Chou K.B., Takeda J., Sachais B.S., Krause J.E. Biochem. Biophys. Res. Comm. 179:1991;1232.
29. Oriowo M.A., Chapman H., Kirkham D.M., Sennitt M.V., Ruffolo R.R., Cawthorne M.A. J. Pharmacol. Exp. Ther. 277:1996;22.